1 / 4

Tirzepatide

As a combined agonist of the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors, it enhances the body's natural ability to regulate blood sugar and decrease appetite. The synergy between these two pathways is crucial, as it not only aids in weight reduction but also improves glycemic control. Visit:https://pommiermedspa.com/semaglutide-and-tirzepatide/

davidanderson65151
Download Presentation

Tirzepatide

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Tirzepatide: Innovative Weight Loss Treatment An FDA-approved injectable for chronic weight management since 2023, Tirzepatide is the active ingredient in Mounjaro (diabetes) and Zepbound (weight loss). It targets adults with obesity or those overweight with related conditions, combining medication with diet and exercise for optimal results.

  2. How Tirzepatide Works Dual Agonist Action Targets GIP and GLP-1 receptors, mimicking natural gut hormones. Appetite & Gastric Emptying Decreases appetite and slows down stomach emptying, promoting fullness. Insulin & Glucose Enhances insulin release and reduces liver glucose production for better blood sugar control.

  3. Safety and Side Effects Common Side Effects Rare Risks Potential risks include thyroid C-cell tumors (relevance to humans unknown), pancreatitis, and gallbladder issues. Typically include nausea, diarrhea, vomiting, constipation, and abdominal pain. These are usually mild to moderate and often occur during dose escalation. Contraindications Not recommended for individuals with type 1 diabetes or a history of medullary thyroid carcinoma.

  4. Contact Us Address Phone Email 13119 Elk Mountain Dr, Riverview, FL, United States, Florida +1 813-343-2860 manager@pommiermedspa.com

More Related